Delaware could bring in $43 million a year in revenue if it legalizes and taxes marijuana, according to a report Monday from the state auditor.
The report estimated 13% of adults in the state would consume marijuana based on data from the Substance Abuse and Mental Health Services Administration and assumed a 20% tax on the plant to get to the $43 million figure.
“That money could be used to plug budget holes in the short term and would continue to provide revenue for all kinds of important initiatives in the long term,” Auditor Kathy McGuiness, who supports legalization, said in a statement.
The report also concluded that legalization would create more than 1,000 new jobs over the course of five years, creating a $215 million industry in Delaware.
It comes as lawmakers have just begun the 2021 legislative session, where a bill to legalize marijuana is sure to come up.
While the legal weed fight in Delaware has been perennially unsuccessful over the past several years, advocates think more pressure is on Delaware to pass it than ever before. [Read more at Delaware Online]
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me of follow-up comments by email.
Notify me of new posts by email.
POSaBIT, the cannabis point-of-sale (POS) and payments software company, this morning announced its planned acquisition of MJ Platform (MJ Freeway), Leaf Data Systems, and Ample Organics from embattled software company…
New York marijuana regulators on Wednesday approved dozens of conditional adult-use dispensary licenses in a session during which members also discussed adopting bylaws for how the board runs meetings and makes decisions.…
By Griffin Thorne, Attorney at Harris Bricken Since the passage of the 2018 Farm Bill, the hemp CBD industry has been eagerly awaiting FDA CBD regulations. In that time, FDA…
The US Food and Drug Administration has finalized a 2020 draft guidance outlining how sponsors and investigators can conduct clinical trials for certain drugs containing cannabis or cannabis-derived compounds without…